TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NPCE

Neuropace Inc

Healthcare · Medical Devices · —

14.70$ +1.2% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NPCE
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
96.0% 97.5% 99.4% 85.6% 86.1% 85.9% 89.1%
19.5% 47.2% 14.4% 5.8% 16.8% 14.2% 20.5%
24.1% 68.1% 86.5% 67.8% 61.7% 55.7% 57.8%
28.5% 15.0% 5.3% 6.6% 11.4% 13.6% 13.9%
37.4% 12.3% 5.9% 8.5% 10.4% 14.1% 16.0%
3.8% 0.9% 0.5% 0.9%
713.2% 364.2% 45.0% 69.5% 80.8% 91.5% 82.0%
356.2% 17.1% 7.0% 9.6% 15.1% 16.0% 16.9%
297.7% 3.7% 1.2% 1.5% 2.0% 2.0%
4.3% 1.7% 1.0% 1.9% 2.2% 3.1% 2.1%
90.8% 37.3% 46.4% 52.9% 62.9% 55.8%
-613.2% -264.2% 55.0% 30.5% 19.2% 8.5% 18.0%
-1,723.8% -692.9% -317.3% -412.6% -468.0% -561.0% -523.3%
52.6% 19.8% 12.4% 21.6% 24.0% 30.8% 31.0%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?